4-hydroxyphenylethanol has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antonopoulou, S; Apostolakis, C; Fragopoulou, E; Karantonis, HC; Nomikos, T; Panayotou, G; Pliakis, E; Samiotaki, M | 1 |
Antonopoulou, S; Fragopoulou, E; Kostakis, IK; Stamatakis, GM; Vlachogianni, IC | 1 |
2 other study(ies) available for 4-hydroxyphenylethanol and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Article | Year |
---|---|
Biological activity of acetylated phenolic compounds.
Topics: Acetylation; Animals; Chromatography, High Pressure Liquid; Phenylethyl Alcohol; Platelet Activating Factor; Platelet Aggregation; Rabbits; Resveratrol; Spectrometry, Mass, Electrospray Ionization; Stilbenes | 2007 |
Platelet Activating Factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetylation; Acetyltransferases; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cell Line; Diacylglycerol Cholinephosphotransferase; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Humans; Interleukin-1beta; Monocytes; Osmolar Concentration; Phenylethyl Alcohol; Platelet Activating Factor; Recombinant Proteins; Resveratrol; Stilbenes | 2015 |